Clinical Value of SARS-CoV2 IgM and IgG Antibodies in Diagnosis of COVID-19 in Suspected Cases
Yangchun Feng Clinical Laboratory Center, The Third Hospital Affiliated to Xinjiang Medical University (Affiliated Cancer Hospital), Urumqi, 830011, People’s Republic of ChinaCorrespondence: Yangchun FengThird Hospital Affiliated to Xinjiang Medical University (Affiliated Cancer Hospital),...
Guardado en:
Autor principal: | Feng Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/900b70e0ffa54013b7d1086a62c23ade |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG
por: Jamiruddin MR, et al.
Publicado: (2021) -
Serology assessment of antibody response to SARS-CoV-2 in patients with COVID-19 by rapid IgM/IgG antibody test
por: Yang De Marinis, et al.
Publicado: (2020) -
Validation of rapid antibody (IgG-IgM) test kit for SARS COV-2 infection in Qatar
por: Jesha Mundodan, et al.
Publicado: (2021) -
EDTA-K2 Improves the Detection Sensitivity of SARS-CoV-2 IgM and IgG Antibodies by Chelating Colloidal Gold in the Immunochromatographic Assay
por: Hu X, et al.
Publicado: (2021) -
Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2
por: Tove Hoffman, et al.
Publicado: (2020)